MedTrace Logo

Steroid Therapy in Acute Bronchiolitis A New Old Line of Therapy.

NCT03436225 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-01-09

No results posted yet for this study

Summary

The aim of the present study is to evaluate the efficacy of steroid therapy and hospital stay in patients with acute bronchiolitis at assiut university children hospital.

Conditions

  • Bronchiolitis; Respiratory Syncytial Virus

Interventions

DRUG

Dexamethasone orally.

Administered orally (0.15mg /kg / dose) twice daily for 3 to 5 days.

DRUG

Dexamethasone parenteral.

Administered parenteral (0.15mg /kg / dose) twice daily for 3 to 5 days.

DRUG

Inhaled nebulized Budesonide.

Administered for inhalation (1 mg/ 2ml) twice daily for 3 to 5 days.

DRUG

Inhaled nebulized salbutamol.

Administered for inhalation (0.15mg /kg / dose) daily every 6-8hrs

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
3 Months
Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-28
Primary Completion
2019-02-28
Completion
2019-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03436225 on ClinicalTrials.gov